This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Tricyclics for chronic pain syndromes

Authoring team

Tricyclic antidepressants can be used for in the management of a range of chronic pain syndromes, including:

  • neuropathic pain:
    • post-herpetic neuralgia
    • diabetic neuropathy
  • post-stroke pain
  • irritable bowel syndrome
  • temporomandibular joint dysfunction
  • atypical facial pain
  • fibromyalgia
  • migraine

In many of these conditions 50-90% of patients can be expected to achieve a 50% or greater reduction in pain. The number of patients needed to be treated in order to achieve a 50% reduction in pain in an individual patient are:

  • 3.0 in diabetic neuropathy
  • 2.8 in atypical facial pain
  • 1.7 in post-stroke pain

The trial evidence is generally for low dose amitriptyline. Other antidepressants may be effective.

For full guidance then see linked item regarding NICE guidance below. Consult the respect Summary of Product Characteristic (SPC) of any medication mentioned before prescribing.


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.